MULTI-STATE MODELS ENHANCE INSIGHT IN OUTCOMES AFTER ALLOGENEIC STEM CELL TRANSPLANTATION FOR AML/MDS FOLLOWED BY DONOR LYMPHOCYTE INFUSIONS

被引：0
|
作者：
de Wreede, L. [1 ]
Eefting, M. [2 ]
Halkes, C. [2 ]
von dem Borne, P. [2 ]
Kersting, S. [2 ]
Marijt, E. [2 ]
Veelken, H. [2 ]
Putter, H. [1 ]
Schetelig, J. [3 ]
Falkenburg, J. [2 ]
机构：
[1] LUMC, Med Stat & Bioinformat, Leiden, Netherlands
[2] LUMC, Hematol, Leiden, Netherlands
[3] Univ Hosp Carl Gustav Carus, Dept Med 1, Dresden, Germany
来源：
BONE MARROW TRANSPLANTATION | 2014年 / 49卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
PH-P399
引用
收藏
页码：S291 / S291
页数：1
相关论文
共 50 条
  • [31] Durable remission after prophylactic donor lymphocyte transfusion following allogeneic stem cell transplantation with reduced conditioning for high-risk AML and MDS
    Schleuning, M
    Schmid, C
    Ledderose, G
    Tischer, J
    Humann, M
    Ullmann, J
    Schwerdtfeger, R
    Kolb, HJ
    BLOOD, 2004, 104 (11) : 89A - 89A
  • [32] Maintenance immunotherapy by repetitive low-dose donor lymphocytes infusions in a child with relapse state AML after allogeneic stem cell transplantation
    Hartwig, M.
    Weigel, S.
    Bernig, T.
    Bader, P.
    Doelken, R.
    Beck, J.
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2007, 24 (02) : 137 - 140
  • [33] Donor lymphocyte infusions after haplo identical haematopoietic stem cell transplantation
    Stadler, M.
    Bethge, W.
    Schleuning, M.
    Bornhaeuser, M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S127 - S127
  • [34] Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation
    Z Jedlickova
    C Schmid
    C Koenecke
    B Hertenstein
    H Baurmann
    R Schwerdtfeger
    J Tischer
    H-J Kolb
    M Schleuning
    Bone Marrow Transplantation, 2016, 51 : 663 - 667
  • [35] Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation
    Jedlickova, Z.
    Schmid, C.
    Koenecke, C.
    Hertenstein, B.
    Baurmann, H.
    Schwerdtfeger, R.
    Tischer, J.
    Kolb, H-J
    Schleuning, M.
    BONE MARROW TRANSPLANTATION, 2016, 51 (05) : 663 - 667
  • [36] Dose-reduced conditioning followed by allogeneic stem cell transplantation in patients with MDS or secondary AML
    Kröger, N
    Schwerdtfeger, R
    Bornhäuser, M
    Ehninger, G
    Runde, V
    Beyer, J
    Kiehl, M
    Schetelig, J
    Siegert, W
    Schäfer-Eckert, K
    Wandt, H
    Sayer, HG
    Kröger, M
    Zabelina, T
    Zander, AR
    BONE MARROW TRANSPLANTATION, 2002, 29 : S57 - S57
  • [37] Treatment of MDS, AML and CMML Relapse after Allogeneic Blood Stem Cell Transplantation with Azacitidine, Lenalidomide and Donor Lymphocyte Infusions - Final Results of the Prospective Azalena-Trial (NCT02472690
    Schroeder, Thomas
    Stelljes, Matthias
    Chirstopeit, Maximilian
    Schmidt, Eva
    Scheid, Christoph
    Mikesch, Jan-Henrik
    Rautenberg, Christina
    Jaeger, Paul
    Drusenheimer, Nadja
    Holtick, Udo
    Klein, Stefan
    Trenschel, Rudolf
    Haas, Rainer
    Germing, Ulrich
    Kroeger, Nicolaus
    Kobbe, Guido
    BLOOD, 2021, 138
  • [38] Azacitidine and donor lymphocyte infusion in relapsed AML or MDS after allogeneic stem cell transplant: a single-centre analysis
    Martinez-Cibrian, N.
    Dignan, F.
    Saif, M.
    Davis, E.
    Tholouli, E.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S390 - S391
  • [39] Donor lymphocyte infusions after haploidentical allogeneic haematopoietic stem cell transplantation are associated with inferior survival in myeloid neoplasms
    Benoit, T. M.
    Wolfensberger, N.
    Bachofner, A.
    Manz, M. G.
    Schneidawind, D.
    SWISS MEDICAL WEEKLY, 2023, 153 : 46S - 47S
  • [40] Late response to donor lymphocyte infusions in patients with chronic myeloid leukemia relapsing after allogeneic stem cell transplantation
    Gómez, M
    Urbano-Ispizua, A
    Cervantes, F
    Fernández-Avilés, F
    Rovira, M
    Carreras, E
    HAEMATOLOGICA, 2002, 87 (09) : 1003 - 1005
12345